The University of Wisconsin Comprehensive Cancer Center (UWCCC) was established in 1973 as a comprehensive, matrix center. By fostering and coordinating cancer research, it plays a leading role in the Medical School, on campus and in the region. Its 167 members, from 38 departments and eight different University schools participate in nine research programs: Breast Cancer, Urologic Cancer, Cell Adhesion and Signaling, Ocular Tumors, Immunology and Biological Therapeutics, Radiation Oncology and Physics, Developmental Therapeutics, Pediatric Oncology and Cancer Control. These programs encompass laboratory, clinical and population- based research and emphasize translation. Members have explored in laboratory and clinic the use and mechanisms of such anti-cancer agents as fluorouracil, perillyl alcohol, interferon, interleukin 2, monoclonal antibodies, tamoxifen and difluoromethylornithine. They have made fundamental discoveries about bladder, colon, and breast cancer etiology and the mechanisms of malignant transformation. Members' pain control projects have lead to cancer pain initiatives now located in every state and impacting internationally. Epidemiologic studies of women in Wisconsin have revealed modifiable factors that may decrease the risk of breast and bowel cancers. UWCCC has created a supportive environment for new and established investigators. Nine shared resources and the center's space, computing infrastructure, and common equipment serve members effectively. Biostatistics and the Clinical Trials Research Office are model shared resource. Flow Cytometry, the Analytical Laboratory, the Transgenic Animal and Scientific Instrumentation Facilities benefit many programs and projects. The present application, under new UWCCC Director John E. Niederhuber, M.D., requests renewal of comprehensive status and three years of support for key leaders, staff investigators, shared resources, and planning and evaluation. It describes the planned merger with McArdle Laboratory for Cancer Research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-26
Application #
2558456
Study Section
Subcommittee G - Education (NCI)
Program Officer
Mccormick, Patricia
Project Start
1976-01-01
Project End
2001-03-31
Budget Start
1998-06-24
Budget End
1999-03-31
Support Year
26
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Chang, Julie E; Carmichael, Lakeesha L; Kim, KyungMann et al. (2018) VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clin Lymphoma Myeloma Leuk 18:e61-e67
Guerrero, Natalie; Small, Alissa L; Schwei, Rebecca J et al. (2018) Informing physician strategies to overcome language barriers in encounters with pediatric patients. Patient Educ Couns 101:653-658
Chapelin, Fanny; Capitini, Christian M; Ahrens, Eric T (2018) Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer. J Immunother Cancer 6:105
Ni, Dalong; Ferreira, Carolina A; Barnhart, Todd E et al. (2018) Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. J Am Chem Soc 140:14971-14979
Wang, Dongdong; Shi, Ruohong; Zhou, Jiajia et al. (2018) Photo-Enhanced Singlet Oxygen Generation of Prussian Blue-Based Nanocatalyst for Augmented Photodynamic Therapy. iScience 9:14-26
Pearson, Hannah E; Iida, Mari; Orbuch, Rachel A et al. (2018) Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol. Mol Cancer Ther 17:204-214
Mora-Pinzon, Maria C; Trentham-Dietz, Amy; Gangnon, Ronald E et al. (2018) Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk. Nutr Cancer 70:441-446
DuBenske, Lori L; Schrager, Sarina B; Hitchcock, Mary E et al. (2018) Key Elements of Mammography Shared Decision-Making: a Scoping Review of the Literature. J Gen Intern Med 33:1805-1814
Chen, Feng; Goel, Shreya; Shi, Sixiang et al. (2018) General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting. Nano Res 11:4890-4904
Erbe, Amy K; Wang, Wei; Carmichael, Lakeesha et al. (2018) Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res 24:189-196

Showing the most recent 10 out of 1528 publications